Literature DB >> 22014944

Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors.

Jiangbing Zhou1, Toral R Patel, Michael Fu, James P Bertram, W Mark Saltzman.   

Abstract

Therapies based on RNA interference, using agents such as siRNA, are limited by the absence of safe, efficient vehicles for targeted delivery in vivo. The barriers to siRNA delivery are well known and can be individually overcome by addition of functional modules, such as conjugation of moieties for cell penetration or targeting. But, so far, it has been impossible to engineer multiple modules into a single unit. Here, we describe the synthesis of degradable nanoparticles that carry eight synergistic functions: 1) polymer matrix for stabilization/controlled release; 2) siRNA for gene knockdown; 3) agent to enhance endosomal escape; 4) agent to enhance siRNA potency; 5) surface-bound PEG for enhancing circulatory time; and surface-bound peptides for 6) cell penetration; 7) endosomal escape; and 8) tumor targeting. Further, we demonstrate that this approach can provide prolonged knockdown of PLK1 and control of tumor growth in vivo. Importantly, all elements in these octa-functional nanoparticles are known to be safe for human use and each function can be individually controlled, giving this approach to synthetic RNA-loaded nanoparticles potential in a variety of clinical applications. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014944      PMCID: PMC4204797          DOI: 10.1016/j.biomaterials.2011.09.061

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  31 in total

1.  Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma.

Authors:  Siwen Hu-Lieskovan; Jeremy D Heidel; Derek W Bartlett; Mark E Davis; Timothy J Triche
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

2.  Targeted nanoparticles deliver siRNA to melanoma.

Authors:  Yunching Chen; Surendar R Bathula; Qi Yang; Leaf Huang
Journal:  J Invest Dermatol       Date:  2010-08-05       Impact factor: 8.551

3.  Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

Authors:  James O McNamara; Eran R Andrechek; Yong Wang; Kristi D Viles; Rachel E Rempel; Eli Gilboa; Bruce A Sullenger; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2006-06-25       Impact factor: 54.908

Review 4.  Nuclear pore complex proteins.

Authors:  R Bastos; N Panté; B Burke
Journal:  Int Rev Cytol       Date:  1995

5.  Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.

Authors:  Kazuki N Sugahara; Tambet Teesalu; Priya Prakash Karmali; Venkata Ramana Kotamraju; Lilach Agemy; Daniel R Greenwald; Erkki Ruoslahti
Journal:  Science       Date:  2010-04-08       Impact factor: 47.728

6.  Controlled DNA delivery systems.

Authors:  D Luo; K Woodrow-Mumford; N Belcheva; W M Saltzman
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

7.  Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting.

Authors:  Tarek M Fahmy; Robert M Samstein; Casey C Harness; W Mark Saltzman
Journal:  Biomaterials       Date:  2005-04-18       Impact factor: 12.479

8.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

9.  A comprehensive platform for ex vivo T-cell expansion based on biodegradable polymeric artificial antigen-presenting cells.

Authors:  Erin R Steenblock; Tarek M Fahmy
Journal:  Mol Ther       Date:  2008-03-04       Impact factor: 11.454

10.  A status report on RNAi therapeutics.

Authors:  Akshay K Vaishnaw; Jared Gollob; Christina Gamba-Vitalo; Renta Hutabarat; Dinah Sah; Rachel Meyers; Tony de Fougerolles; John Maraganore
Journal:  Silence       Date:  2010-07-08
View more
  54 in total

Review 1.  Novel delivery strategies for glioblastoma.

Authors:  Jiangbing Zhou; Kofi-Buaku Atsina; Benjamin T Himes; Garth W Strohbehn; W Mark Saltzman
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

Review 2.  Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market.

Authors:  Michele F Oliveira; Pedro P G Guimarães; Alinne D M Gomes; Diego Suárez; Rubén D Sinisterra
Journal:  J Chem Biol       Date:  2012-11-30

Review 3.  Nanoscale assemblies and their biomedical applications.

Authors:  Tais A P F Doll; Senthilkumar Raman; Raja Dey; Peter Burkhard
Journal:  J R Soc Interface       Date:  2013-01-09       Impact factor: 4.118

Review 4.  Polymeric nanoparticles for drug delivery to the central nervous system.

Authors:  Toral Patel; Jiangbing Zhou; Joseph M Piepmeier; W Mark Saltzman
Journal:  Adv Drug Deliv Rev       Date:  2011-12-20       Impact factor: 15.470

Review 5.  Systemic delivery to central nervous system by engineered PLGA nanoparticles.

Authors:  Qiang Cai; Long Wang; Gang Deng; Junhui Liu; Qianxue Chen; Zhibiao Chen
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 6.  Non-viral nucleic acid containing nanoparticles as cancer therapeutics.

Authors:  Kristen L Kozielski; Yuan Rui; Jordan J Green
Journal:  Expert Opin Drug Deliv       Date:  2016-06-06       Impact factor: 6.648

7.  Targeted Delivery of CRISPR/Cas9-Mediated Cancer Gene Therapy via Liposome-Templated Hydrogel Nanoparticles.

Authors:  Zeming Chen; Fuyao Liu; Yanke Chen; Jun Liu; Xiaoying Wang; Ann T Chen; Gang Deng; Hongyi Zhang; Jie Liu; Zhangyong Hong; Jiangbing Zhou
Journal:  Adv Funct Mater       Date:  2017-10-16       Impact factor: 18.808

8.  Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.

Authors:  N A McNeer; E B Schleifman; A Cuthbert; M Brehm; A Jackson; C Cheng; K Anandalingam; P Kumar; L D Shultz; D L Greiner; W Mark Saltzman; P M Glazer
Journal:  Gene Ther       Date:  2012-10-18       Impact factor: 5.250

9.  Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.

Authors:  Rachel J Fields; Christopher J Cheng; Elias Quijano; Caroline Weller; Nina Kristofik; Nha Duong; Christopher Hoimes; Marie E Egan; W Mark Saltzman
Journal:  J Control Release       Date:  2012-10-05       Impact factor: 9.776

Review 10.  Materials based tumor immunotherapy vaccines.

Authors:  Weiwei Aileen Li; David J Mooney
Journal:  Curr Opin Immunol       Date:  2013-01-18       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.